HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tianyu Li Selected Research

Matrix Metalloproteinases (MMPs)

4/2022Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke.
10/2021The mitochondria-targeted antioxidant MitoQ attenuated PM2.5-induced vascular fibrosis via regulating mitophagy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tianyu Li Research Topics

Disease

94Neoplasms (Cancer)
06/2024 - 12/2005
31Breast Neoplasms (Breast Cancer)
03/2024 - 12/2005
17Neoplasm Metastasis (Metastasis)
06/2024 - 03/2008
13Inflammation (Inflammations)
12/2023 - 01/2018
13Prostatic Neoplasms (Prostate Cancer)
01/2022 - 11/2007
8Carcinoma (Carcinomatosis)
01/2018 - 10/2007
7Fibrosis (Cirrhosis)
10/2023 - 09/2011
7Cardiovascular Diseases (Cardiovascular Disease)
06/2023 - 09/2012
6Cardiomegaly (Heart Hypertrophy)
04/2024 - 01/2017
6Pancreatic Neoplasms (Pancreatic Cancer)
11/2023 - 01/2020
6Sepsis (Septicemia)
07/2023 - 08/2020
6Obesity
02/2023 - 12/2008
6Coronary Artery Disease (Coronary Atherosclerosis)
11/2022 - 01/2021
5Leukemia
12/2023 - 10/2011
5Wounds and Injuries (Trauma)
10/2022 - 11/2016
4Hypoxia (Hypoxemia)
04/2024 - 01/2020
4Pulmonary Fibrosis (Fibrosing Alveolitis)
07/2023 - 06/2014
4Hypertrophy
06/2023 - 03/2018
4Pathologic Complete Response
01/2023 - 10/2007
4Adenocarcinoma
01/2023 - 08/2007
4Osteoporosis
06/2022 - 10/2020
4Triple Negative Breast Neoplasms
01/2022 - 03/2009
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 05/2016
4Myocardial Infarction
01/2021 - 01/2018
4Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 04/2011
4Reperfusion Injury
01/2020 - 06/2014
4Carcinogenesis
06/2017 - 04/2012
4Esophageal Neoplasms (Esophageal Cancer)
12/2012 - 07/2009
3Colorectal Neoplasms (Colorectal Cancer)
06/2024 - 09/2014
3Mitochondrial Diseases (Mitochondrial Disease)
04/2024 - 10/2021
3Thrombosis (Thrombus)
02/2024 - 01/2020
3Acute Lung Injury
01/2024 - 02/2020
3Melanoma (Melanoma, Malignant)
01/2023 - 01/2018
3Hepatocellular Carcinoma (Hepatoma)
01/2023 - 01/2021
3Atherosclerosis
01/2023 - 01/2022
3Type 2 Diabetes Mellitus (MODY)
09/2022 - 01/2021
3Acute Coronary Syndrome
04/2022 - 01/2021
3Hypertension (High Blood Pressure)
01/2021 - 10/2019
3Rectal Neoplasms (Rectal Cancer)
11/2019 - 05/2009
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2017 - 12/2010
3Noninfiltrating Intraductal Carcinoma (DCIS)
01/2016 - 08/2008
3Cholangiocarcinoma
08/2014 - 07/2010
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2013 - 04/2012

Drug/Important Bio-Agent (IBA)

16Biomarkers (Surrogate Marker)IBA
12/2023 - 08/2014
15Proteins (Proteins, Gene)FDA Link
11/2023 - 07/2010
15Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 08/2014
11Long Noncoding RNAIBA
06/2023 - 03/2018
10RNA (Ribonucleic Acid)IBA
10/2023 - 11/2019
9Hormones (Hormone)IBA
01/2023 - 10/2015
8CytokinesIBA
04/2023 - 06/2014
7SeleniumIBA
12/2023 - 08/2014
7CollagenIBA
10/2023 - 06/2014
7Glucose (Dextrose)FDA LinkGeneric
06/2023 - 05/2009
6CateninsIBA
06/2024 - 10/2011
6Messenger RNA (mRNA)IBA
10/2023 - 01/2018
6Trastuzumab (Herceptin)FDA Link
01/2023 - 08/2021
6Particulate MatterIBA
12/2022 - 12/2020
5ErbB Receptors (EGF Receptor)IBA
01/2024 - 09/2014
5AntioxidantsIBA
02/2023 - 06/2018
5Estrogens (Estrogen)FDA Link
01/2021 - 12/2005
4Estrogen ReceptorsIBA
03/2024 - 12/2005
4MicroRNAs (MicroRNA)IBA
12/2023 - 06/2014
4Small Interfering RNA (siRNA)IBA
12/2023 - 08/2014
4seleninic acidIBA
06/2023 - 02/2020
4Paclitaxel (Taxol)FDA LinkGeneric
01/2023 - 11/2021
4PolymersIBA
01/2023 - 01/2017
4pertuzumabIBA
01/2023 - 09/2021
4pembrolizumabIBA
10/2022 - 01/2020
3C-Reactive ProteinIBA
04/2024 - 06/2023
3mitoquinoneIBA
04/2024 - 10/2021
3Phenobarbital (Luminal)FDA Link
03/2024 - 01/2018
3Indicators and Reagents (Reagents)IBA
12/2023 - 05/2007
3DNA (Deoxyribonucleic Acid)IBA
10/2023 - 09/2021
3Sirtuin 1IBA
06/2023 - 10/2022
3LipopolysaccharidesIBA
01/2023 - 02/2020
3Interleukin-6 (Interleukin 6)IBA
01/2023 - 01/2020
3Transcription Factors (Transcription Factor)IBA
01/2023 - 01/2017
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2022 - 07/2012
3LuciferasesIBA
12/2022 - 03/2018
3human ERBB2 proteinIBA
10/2022 - 09/2021
3Cisplatin (Platino)FDA LinkGeneric
03/2022 - 01/2017
3NucleotidesIBA
01/2022 - 06/2014
3Circular RNAIBA
01/2022 - 05/2021
3LigandsIBA
01/2022 - 10/2011
3eribulinFDA Link
09/2021 - 10/2020
3Carrier Proteins (Binding Protein)IBA
08/2020 - 01/2017
3Interferon Regulatory Factor-2 (Interferon Regulatory Factor 2)IBA
08/2020 - 01/2017
3HomocysteineIBA
01/2019 - 01/2015
3PlatinumIBA
06/2018 - 08/2014

Therapy/Procedure

38Therapeutics
03/2024 - 12/2006
25Radiotherapy
03/2022 - 10/2007
17Drug Therapy (Chemotherapy)
01/2024 - 03/2009
8Immunotherapy
12/2023 - 03/2020
8Segmental Mastectomy (Lumpectomy)
01/2023 - 03/2009
7Percutaneous Coronary Intervention
01/2023 - 01/2021
6Neoadjuvant Therapy
01/2022 - 08/2008
5Chemoradiotherapy
12/2012 - 10/2007
4Adjuvant Chemotherapy
01/2023 - 06/2014
4Nephrectomy
01/2019 - 10/2011
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2013